Gliomas

A Multicentre, Retrospective-prospective Real-world Study: to Evaluate the Effectiveness and Safety of Vorasidenib in Patients With Isocitrate Dehydrogenase IDH1/2 Mutant Grade 2 Astrocytoma or Oligodendroglioma (VICTORIA Study)

Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy

Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas

Nivolumab for Recurrent or Progressive IDH Mutant Gliomas

Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:

Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors

Chronic Convection Enhanced Delivery of Topotecan

Ultralow Dose PET Imaging of 18F-FDOPA

Location-Molecular Integrated Outcomes in 450 Cerebellar Glioma Microsurgical Cases

AI-assisted Diagnosis of Malignant Brain Tumors

A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression

Surgical Suction Aspirates Fluorescence Measurement

Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR

177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors

A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research Purposes

ZOOMit-fMRI Identifies Motor Functional Cortex

Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs

[18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors

Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma

A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade Gliomas